MRFR has flourished a research on “Amniotic Membrane Market 2025”
Market
Analysis:
The
amniotic membrane market size is anticipated to touch USD 2,690.22 million at a
12.67% CAGR between 2019-2025, states the latest Market Research Future (MRFR)
report. The amniotic membrane, also known as amnion, is the deepest layer of
the placenta that comprises of an avascular stromal matrix and a thick basement
membrane. It is a combination of cells and tissues that aid in wound healing by
serving as the foundation for the soft tissues to regrow. Amniotic membrane is
widely used as a biological bandage in eye surgery for healing or replacing
damaged eye tissue.
Various
factors are propelling the amniotic membrane market growth. Such factors, as
per the latest Market Research Future report, include its extensive
applications in head and neck, brain, skin, genitourinary tract, ophthalmology,
and other surgical methods, increasing research activities worldwide, and
increasing geriatric population. Additional factors propelling the growth of
the amniotic membrane market include increasing amniotic membrane transplantations
and rising disease awareness.
On
the contrary, lack of awareness about amniotic membrane transplants, scarcity
of skilled professionals, and rising healthcare costs are factors that may
restrict the amniotic membrane market growth during the forecast period.
Key
Players:
Osiris Therapeutics, Inc. (US), Amnio
Technology, LLC (US), Human Regenerative Technologies, LLC (US), Katena
Products, Inc. (US), Amniox Medical, Inc. (Florida), MiMedx (US), Skye
Biologics Inc. (California), Integra LifeSciences (US), AlliquaBioMedical, Inc.
(US), and Applied Biologics
(US)
Market
Segmentation:
The
Market Research Future report provides an all-inclusive segmental analysis of
the amniotic membrane market on the basis of type & technology
(application), and end user.
By
type, the Amniotic
Membrane Market is segmented into lyophilized and cryopreserved. Of
these, the cryopreserved type will lead the market during the forecast period
for the increasing number of ocular surgeries.
By
application, the amniotic membrane market is segmented into prenatal diagnosis,
regenerative medicine, stem cell biology, ophthalmology, surgical wounds, and
others. Of these, the ophthalmology segment will dominate the market during the
forecast period. It is used to treat various conditions such as conjunctival
surface reconstruction, persistent epithelial defects with ulceration,
pterygium, Stevens-Johnson syndrome, cicatricial pemphigoid, and ocular surface
reconstruction in those with thermal and chemical burns.
By
end user, the amniotic membrane market is segmented into hospitals and clinics,
research centers and laboratory, ambulatory surgical centers, and others. Of
these, hospitals and clinics will hold the maximum share in the market during
the forecast period due to frequent visits made by patients, along with its
ability to cater to different surgical interventions.
Regional
Analysis:
By
region, the amniotic membrane market report covers the latest trends and growth
opportunities across Europe, the Asia Pacific, North America, and the Middle
East and Africa. Of these, North America will lead the market during the
forecast period. Various factors propelling the growth of the amniotic membrane
market in the region include growing focus on alternative technologies,
adoption of the latest technologies, and the presence of leading companies and
well-developed healthcare infrastructure in the region.
The
amniotic membrane market in Europe will have the second-largest share in the
market during the forecast period. Various factors propelling the growth of the
amniotic membrane market in the region include the healthcare system in the
region is publicly funded, adoption of universal health care systems, the
presence of target population, increase in surgical interventions, and rising
incidence of chronic diseases. Germany as well as France are the major
contributors in the region.
Access
Full Report Details @
https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645
The
amniotic membrane market in the APAC region is predicted to grow at the highest
CAGR during the forecast period. Various factors propelling the growth of the
amniotic membrane market in the region include developing economy, increasing
disposable income, heavy investments being made in the region by multinational
companies, and the presence of countries that are technologically advanced with
regards to medical and healthcare research. India is a major contributor in
this region.
The
amniotic membrane market in the MEA will have a small share during the forecast
period.
Industry
News
July
2019: Americord Registry has launched Placental Tissue 2.0, its latest stem
cell banking product. This exciting product is the first in the industry that
will help to store live amniotic membrane. Placental Tissue 2.0 will allow
people to store two kinds of valuable stem cells- MSCs (mesenchymal stem cells)
and AECs (amniotic epithelial cells).
No comments:
Post a Comment